These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32668490)

  • 21. [Nocturnal polyuria, treatment with desmopressin].
    Zachoval R; Krhut J; Šottner O; Hanuš T; Martan A; Horčička L; Feyereisl J; Halaška M; Švabík K; Krofta L
    Ceska Gynekol; 2013 Aug; 78(4):385-9. PubMed ID: 24040989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose Desmopressin Orally Disintegrating Tablet: Suggested Clinically Meaningful Benefit in Patients with Nocturia Due to Nocturnal Polyuria.
    Weiss JP; van der Meulen EA; Juul KV
    Eur Urol Focus; 2020 Sep; 6(5):1006-1012. PubMed ID: 30470646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of desmopressin for the treatment of nocturia in elderly patients: a cohort study.
    Song M; Hong BS; Chun JY; Han JY; Choo MS
    Int Urol Nephrol; 2014 Aug; 46(8):1495-9. PubMed ID: 24595604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desmopressin acetate the first sublingual tablet to treat nocturia due to nocturnal polyuria.
    Alford N; Hashim H
    Expert Rev Clin Pharmacol; 2021 Aug; 14(8):939-954. PubMed ID: 33993824
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of nocturia response to desmopressin treatment between patients with normal and high nocturnal bladder capacity index.
    Hajdinjak T; Leskovar J
    ScientificWorldJournal; 2013; 2013():878564. PubMed ID: 24223034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of intranasal desmopressin for the treatment of nocturnal polyuria in the elderly females].
    Kayamori K; Fujitani J; Kawachi S
    Nihon Ronen Igakkai Zasshi; 2014; 51(1):85-8. PubMed ID: 24747505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thinking beyond the bladder: antidiuretic treatment of nocturia.
    van Kerrebroeck P; Hashim H; Holm-Larsen T; Robinson D; Stanley N
    Int J Clin Pract; 2010 May; 64(6):807-16. PubMed ID: 20337753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy for nocturia in the elderly patient.
    Asplund R
    Drugs Aging; 2007; 24(4):325-43. PubMed ID: 17432926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The risk of hyponatremia with desmopressin use for nocturnal polyuria.
    Choi EY; Park JS; Kim YT; Park SY; Kim GH
    Am J Nephrol; 2015; 41(3):183-90. PubMed ID: 25871541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial.
    Yamaguchi O; Nishizawa O; Juul KV; Nørgaard JP
    BJU Int; 2013 Mar; 111(3):474-84. PubMed ID: 23046147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
    Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
    J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nocturia in men with benign prostatic hyperplasia].
    Oelke M; Fangmeyer B; Zinke J; Witt JH
    Aktuelle Urol; 2018 Aug; 49(4):319-327. PubMed ID: 30086589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Desmopressin add-on therapy for refractory nocturia in men receiving α-blockers for lower urinary tract symptoms.
    Bae WJ; Bae JH; Kim SW; Chung BH; Kim JH; Kim CS; Lee HM; Lee KS; Yoo TK; Kim SI; Byun SS; Lee JY
    J Urol; 2013 Jul; 190(1):180-6. PubMed ID: 23357213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electroencephalography-based investigation of the effects of oral desmopressin on improving slow-wave sleep time in nocturnal polyuria patients (the DISTINCT study): A single-arm, open-label, single-assignment trial.
    Torimoto K; Gotoh D; Nakai Y; Miyake M; Fujimoto K
    Neurourol Urodyn; 2024 Sep; 43(7):1559-1565. PubMed ID: 38606623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maximal bladder capacity is a positive predictor of response to desmopressin treatment in patients with MS and nocturia.
    Zahariou A; Karamouti M; Karagiannis G; Papaioannou P
    Int Urol Nephrol; 2008; 40(1):65-9. PubMed ID: 17610036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of desmopressin in nocturia and nocturnal polyuria control of neurological patients: A systematic review and meta-analysis.
    Hajebrahimi S; Darvishi A; HajEbrahimi R; Asadi N; Jafari Shendi Z; Asiaban N; Naseri A; Sadeghi-Ghyassi F; Mostafaei H; Salehi-Pourmehr H
    Neurourol Urodyn; 2024 Jan; 43(1):167-182. PubMed ID: 37746880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desmopressin in the treatment of nocturnal polyuria in the male.
    Cannon A; Carter PG; McConnell AA; Abrams P
    BJU Int; 1999 Jul; 84(1):20-4. PubMed ID: 10444118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationale, design, and methods of electroencephalography-based investigation of the effects of oral desmopressin on improving slow-wave sleep time in nocturnal polyuria patients (the DISTINCT study): protocol for a single-arm, open-label, single-assignment trial.
    Torimoto K; Miyake M; Nakai Y; Aoki K; Tanaka N; Fujimoto K
    BMC Urol; 2020 Jul; 20(1):96. PubMed ID: 32652972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical observations of the effect of antidiuretic hormone on nocturia in elderly men.
    Ho DR; Lin WY; Wu CF; Shee JJ; Huang YC; Chen CS
    BJU Int; 2005 Dec; 96(9):1310-3. PubMed ID: 16287451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Urinary Aquaporin 2 and Plasma Copeptin as Biomarkers of Effectiveness of Desmopressin Acetate for the Treatment of Monosymptomatic Nocturnal Enuresis.
    Hara T; Ohtomo Y; Endo A; Niijima S; Yasui M; Shimizu T
    J Urol; 2017 Oct; 198(4):921-927. PubMed ID: 28457803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.